- Home
- HURA vs RMNI Comparison
HURA vs RMNI Comparison
Compare HURA & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- RMNI
- Stock Information
- Founded
- HURA 2009
- RMNI 2005
- Country
- HURA United States
- RMNI United States
- Employees
- HURA N/A
- RMNI N/A
- Industry
- HURA
- RMNI Business Services
- Sector
- HURA
- RMNI Consumer Discretionary
- Exchange
- HURA Nasdaq
- RMNI Nasdaq
- Market Cap
- HURA 246.9M
- RMNI 256.4M
- IPO Year
- HURA N/A
- RMNI N/A
- Fundamental
- Price
- HURA $4.76
- RMNI $2.75
- Analyst Decision
- HURA Strong Buy
- RMNI Buy
- Analyst Count
- HURA 1
- RMNI 2
- Target Price
- HURA $11.00
- RMNI $6.00
- AVG Volume (30 Days)
- HURA 262.4K
- RMNI 338.5K
- Earning Date
- HURA 02-15-2025
- RMNI 02-26-2025
- Dividend Yield
- HURA N/A
- RMNI N/A
- EPS Growth
- HURA N/A
- RMNI N/A
- EPS
- HURA N/A
- RMNI N/A
- Revenue
- HURA N/A
- RMNI $426,650,000.00
- Revenue This Year
- HURA N/A
- RMNI N/A
- Revenue Next Year
- HURA N/A
- RMNI N/A
- P/E Ratio
- HURA N/A
- RMNI N/A
- Revenue Growth
- HURA N/A
- RMNI N/A
- 52 Week Low
- HURA $2.84
- RMNI $1.53
- 52 Week High
- HURA $14.60
- RMNI $3.43
- Technical
- Relative Strength Index (RSI)
- HURA N/A
- RMNI 57.42
- Support Level
- HURA N/A
- RMNI $2.71
- Resistance Level
- HURA N/A
- RMNI $2.91
- Average True Range (ATR)
- HURA 0.00
- RMNI 0.17
- MACD
- HURA 0.00
- RMNI -0.01
- Stochastic Oscillator
- HURA 0.00
- RMNI 61.90
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc is a provider of enterprise software support products and services and a third-party support provider for Oracle and SAP software products based in the United States. The company offers solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. Some of its products include Oracle E-business suite, Oracle Database, Peoplesoft, SAP business suite, and others. The company derives maximum revenue from United states.